Published in Clin Cancer Res on May 15, 2004
Over-expression of c-kit in a primary leiomyosarcoma of the thyroid gland. Eur Arch Otorhinolaryngol (2007) 0.89
Imatinib is not a potential alternative treatment for uterine leiomyosarcoma. Clin Cancer Res (2005) 0.85
Leiomyosarcoma of the thyroid gland: A case report and literature review. Oncol Lett (2014) 0.85
Differential diagnosis of gastrointestinal leiomyoma versus gastrointestinal stromal tumor. Int J Colorectal Dis (2005) 0.80
Current Chemotherapy and Potential New Targets in Uterine Leiomyosarcoma. J Clin Med Res (2016) 0.78
Uterine C-Kit positive low grade stromal sarcoma. Indian J Med Paediatr Oncol (2009) 0.76
Primary Sarcomas of Thyroid Gland-Series of Three Cases with Brief Review of Spindle Cell Lesions of Thyroid. J Clin Diagn Res (2017) 0.75
Quantitative real-time reverse transcription polymerase chain reaction: normalization to rRNA or single housekeeping genes is inappropriate for human tissue biopsies. Anal Biochem (2002) 4.84
Application of a filtration- and isolation-by-size technique for the detection of circulating tumor cells in cutaneous melanoma. J Invest Dermatol (2010) 3.26
Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer: results from the Italian multicenter randomized study. J Clin Oncol (2002) 2.27
Metalloproteinases-2, -9 and TIMP-1 expression in stable and unstable coronary plaques undergoing PCI. Int J Cardiol (2007) 2.05
Estrogen receptor expression in cutaneous melanoma: a real-time reverse transcriptase-polymerase chain reaction and immunohistochemical study. Arch Dermatol (2009) 1.67
Circulating benign nevus cells detected by ISET technique: warning for melanoma molecular diagnosis. Arch Dermatol (2010) 1.46
Evidence for differential expression of Notch receptors and their ligands in melanocytic nevi and cutaneous malignant melanoma. Mod Pathol (2006) 1.46
Sinonasal undifferentiated carcinoma, nasopharyngeal-type undifferentiated carcinoma, and keratinizing and nonkeratinizing squamous cell carcinoma express different cytokeratin patterns. Am J Surg Pathol (2002) 1.27
Prognostic significance of cyclooxygenase-2 pathway and angiogenesis in head and neck squamous cell carcinoma. Hum Pathol (2002) 1.27
The use of COLD-PCR and high-resolution melting analysis improves the limit of detection of KRAS and BRAF mutations in colorectal cancer. J Mol Diagn (2010) 1.26
Expression of matrix metalloproteinase 1, matrix metalloproteinase 2, and matrix metalloproteinase 9 in carcinoma of the head and neck. Cancer (2002) 1.25
Cerebellar liponeurocytoma: morphological, immunohistochemical, and ultrastructural study of a relapsed case. Neuropathology (2005) 1.25
BRCA1 and BRCA2 mutation status and tumor characteristics in male breast cancer: a population-based study in Italy. Cancer Res (2003) 1.22
Antitumorigenic activity of the prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis on azoxymethane-induced colon carcinogenesis in rats. Carcinogenesis (2002) 1.13
Expression of protease-activated receptors 1 and 2 in melanocytic nevi and malignant melanoma. Hum Pathol (2005) 1.10
Human striatal neuroblasts develop and build a striatal-like structure into the brain of Huntington's disease patients after transplantation. Exp Neurol (2009) 1.10
Genetic variants in miR-146a, miR-149, miR-196a2, miR-499 and their influence on relative expression in lung cancers. Clin Chem Lab Med (2011) 1.09
Genetic and epigenetic factors in regulation of microRNA in colorectal cancers. Methods (2012) 1.07
MRE11 expression is impaired in gastric cancer with microsatellite instability. Carcinogenesis (2004) 1.06
Plasma cell granuloma--an enigmatic lesion: description of an extensive intracranial case and review of the literature. Arch Pathol Lab Med (2003) 1.04
Association between single nucleotide polymorphisms in the XRCC1 and RAD51 genes and clinical radiosensitivity in head and neck cancer. Radiother Oncol (2011) 1.04
Recommendations for mutational analysis of EGFR in lung carcinoma. Pathologica (2010) 1.00
Luteinizing hormone increases human endometrial cancer cells invasiveness through activation of protein kinase A. Cancer Res (2003) 1.00
Tankyrase, a positive regulator of telomere elongation, is over expressed in human breast cancer. Cancer Lett (2004) 0.98
Embryonal tumor with abundant neuropil and true rosettes: morphological, immunohistochemical, ultrastructural and molecular study of a case showing features of medulloepithelioma and areas of mesenchymal and epithelial differentiation. Neuropathology (2009) 0.98
BRAFV600E detection in melanoma is highly improved by COLD-PCR. Clin Chim Acta (2011) 0.98
The CXCR4/CXCL12 axis in endometrial cancer. Clin Exp Metastasis (2009) 0.97
Multiparametric analysis of cell-free DNA in melanoma patients. PLoS One (2012) 0.97
Unbalanced GLA mRNAs ratio quantified by real-time PCR in Fabry patients' fibroblasts results in Fabry disease. Eur J Hum Genet (2008) 0.96
ErbB-receptors expression and survival in breast carcinoma: a 15-year follow-up study. J Cell Physiol (2006) 0.96
Correlation of epidermal growth factor receptor expression with tumor microdensity vessels and with vascular endothelial growth factor expression in ovarian carcinoma. Int J Surg Pathol (2005) 0.96
Androgen receptor regulation of the seladin-1/DHCR24 gene: altered expression in prostate cancer. Lab Invest (2008) 0.94
Real-time PCR analysis of RNA extracted from formalin-fixed and paraffin-embeded tissues: effects of the fixation on outcome reliability. Appl Immunohistochem Mol Morphol (2007) 0.93
Expression of Notch-1 and alteration of the E-cadherin/beta-catenin cell adhesion complex are observed in primary cutaneous neuroendocrine carcinoma (Merkel cell carcinoma). Mod Pathol (2009) 0.92
Congenital/Infantile fibrosarcoma of the colon: morphologic, immunohistochemical, molecular, and ultrastructural features of a relatively rare tumor in an extraordinary localization. J Pediatr Hematol Oncol (2008) 0.92
Recommendations for the analysis of ALK gene rearrangements in non-small-cell lung cancer: a consensus of the Italian Association of Medical Oncology and the Italian Society of Pathology and Cytopathology. J Thorac Oncol (2013) 0.92
VEGF expression in the placenta from pregnancies complicated by hypertensive disorders. BJOG (2004) 0.92
In vivo characterization of the inflammatory infiltrate and apoptotic status in imiquimod-treated basal cell carcinoma. Int J Dermatol (2009) 0.91
hLH/hCG-receptor expression correlates with in vitro invasiveness in human primary endometrial cancer. Gynecol Oncol (2008) 0.90
Frequent loss of expression of the cyclin-dependent kinase inhibitor p27(Kip1) in estrogen-related Endometrial adenocarcinomas. Clin Cancer Res (2003) 0.89
Androgen receptor (AR) expression in prostate cancer and progression of the tumor: Lessons from cell lines, animal models and human specimens. Steroids (2012) 0.89
Mucin-depleted foci have beta-catenin gene mutations, altered expression of its protein, and are dose- and time-dependent in the colon of 1,2-dimethylhydrazine-treated rats. Int J Cancer (2005) 0.89
Alternative splicing variants of carbonic anhydrase IX in human non-small cell lung cancer. Lung Cancer (2008) 0.89
Atypical Spitzoid melanocytic tumors: a morphological, mutational, and FISH analysis. J Am Acad Dermatol (2011) 0.88
COX-2, c-KIT and HER-2/neu expression in uterine carcinosarcomas: prognostic factors or potential markers for targeted therapies? Gynecol Oncol (2005) 0.88
Feasibility of evaluating quality cancer care using registry data and electronic health records: a population-based study. Int J Qual Health Care (2012) 0.88
Distribution of Tankyrase-1 mRNA expression in colon cancer and its prospective correlation with progression stage. Oncol Rep (2006) 0.87
Inducible nitric oxide synthase expression in laryngeal neoplasia: correlation with angiogenesis. Head Neck (2002) 0.87
Type A microsatellite instability in pediatric gliomas as an indicator of Turcot syndrome. Eur J Hum Genet (2009) 0.87
Immunohistochemistry in the differential diagnosis between primary and secondary intestinal adenocarcinoma of the urinary bladder. Appl Immunohistochem Mol Morphol (2005) 0.87
Vaginal hysterectomy and abdominal hysterectomy for treatment of endometrial cancer in the elderly. Gynecol Oncol (2005) 0.87
S100A13 is a new angiogenic marker in human melanoma. Mod Pathol (2010) 0.86
The somatic affairs of BRAF: tailored therapies for advanced malignant melanoma and orphan non-V600E (V600R-M) mutations. J Clin Pathol (2013) 0.86
Coexisting endometrial and ovarian carcinomas: a retrospective clinicopathological study. Pathol Res Pract (2008) 0.86
hERG1 channels in human esophagus: evidence for their aberrant expression in the malignant progression of Barrett's esophagus. J Cell Physiol (2006) 0.86
Hemangioma of the umbilical cord: report of a case. Pathol Res Pract (2003) 0.85
Development of bioengineered human larynx. Biomaterials (2011) 0.85
Expression of cyclooxygenase-2 in osteosarcoma of bone. Appl Immunohistochem Mol Morphol (2007) 0.84
Uncommon clinical presentations of pheochromocytoma and paraganglioma in two different patients affected by two distinct novel VHL germline mutations. Clin Endocrinol (Oxf) (2007) 0.84
Surveillance for endometrial cancer in women on tamoxifen: the role of liquid-based endometrial cytology - cytohistological correlation in a population of 168 women. Gynecol Obstet Invest (2008) 0.83
BRAF and KIT somatic mutations are present in amelanotic melanoma. Melanoma Res (2013) 0.83
External quality assurance program for PCR amplification of genomic DNA: an Italian experience. Clin Chem (2003) 0.83
Tumor angiogenesis as a prognostic factor in thick cutaneous malignant melanoma. A quantitative morphologic analysis. Virchows Arch (2002) 0.83
Extraventricular neurocytoma: morphological and immunohistochemical considerations on differential diagnosis. Pathol Res Pract (2002) 0.83
DNA ploidy is stronger than lymph node metastasis as prognostic factor in cervical carcinoma: 10-year results of a prospective study. Int J Gynecol Cancer (2011) 0.83
Modeled gravitational unloading triggers differentiation and apoptosis in preosteoclastic cells. J Cell Biochem (2006) 0.83
Epidermal growth factor receptor expression and gene copy number in sinonasal intestinal type adenocarcinoma. Oral Oncol (2009) 0.83
Quantitative expression of the homeobox and integrin genes in human gastric carcinoma. Int J Mol Med (2007) 0.83
Detection of circulating tumor cells in patients with adrenocortical carcinoma: a monocentric preliminary study. J Clin Endocrinol Metab (2013) 0.83
HER-2/neu and bcl-2 in ovarian carcinoma: clinicopathologic, immunohistochemical, and molecular study in patients with shorter and longer survival. Appl Immunohistochem Mol Morphol (2006) 0.82
Chordoid glioma: clinicopathologic profile and differential diagnosis of an uncommon tumor. Arch Pathol Lab Med (2004) 0.82
Brain heterotopia in pharyngeal region. A morphological and immunohistochemical study. Pathol Res Pract (2002) 0.82
Merlin expression in secretory meningiomas: evidence of an NF2-independent pathogenesis? Immunohistochemical study. Appl Immunohistochem Mol Morphol (2007) 0.82
Development of human striatal anlagen after transplantation in a patient with Huntington's disease. Exp Neurol (2008) 0.82
Preoperative assessment of HER-2/neu status in breast carcinoma: the role of quantitative real-time PCR on core-biopsy specimens. Gynecol Oncol (2009) 0.82
COX-2 status in relation to tumor microvessel density and VEGF expression: analysis in ovarian carcinoma patients with low versus high survival rates. Oncol Rep (2004) 0.82
Papillary glioneuronal tumor radiologically mimicking a cavernous hemangioma with hemorrhagic onset. Neuropathology (2006) 0.82
p16(INK4a) expression in urinary bladder carcinoma. Arch Ital Urol Androl (2006) 0.82
Calcified cystic lymphangioma of the mesentery: case report. Fetal Pediatr Pathol (2009) 0.82